Gradimir Janković

691 total citations
50 papers, 437 citations indexed

About

Gradimir Janković is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Gradimir Janković has authored 50 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 25 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Gradimir Janković's work include Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Gradimir Janković is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). Gradimir Janković collaborates with scholars based in Serbia, Czechia and United States. Gradimir Janković's co-authors include Milica C̆olović, Nada Suvajdžić, Andrija Bogdanović, Ana Vidović, Nataša Čolović, Nataša Milić, Igor E. Konstantinov, Dragomir Marisavljević, Vladimir Lazarević and Mirjana Gotić and has published in prestigious journals such as Cancer Letters, British Journal of Haematology and Journal of Clinical Pathology.

In The Last Decade

Gradimir Janković

49 papers receiving 425 citations

Peers

Gradimir Janković
A. Lakhani United Kingdom
Ryan J. Mattison United States
Kamal Chamoun United States
Melih Aktan Türkiye
Gradimir Janković
Citations per year, relative to Gradimir Janković Gradimir Janković (= 1×) peers Giuliana Alimena

Countries citing papers authored by Gradimir Janković

Since Specialization
Citations

This map shows the geographic impact of Gradimir Janković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gradimir Janković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gradimir Janković more than expected).

Fields of papers citing papers by Gradimir Janković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gradimir Janković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gradimir Janković. The network helps show where Gradimir Janković may publish in the future.

Co-authorship network of co-authors of Gradimir Janković

This figure shows the co-authorship network connecting the top 25 collaborators of Gradimir Janković. A scholar is included among the top collaborators of Gradimir Janković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gradimir Janković. Gradimir Janković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leković, Danijela, Mirjana Gotić, Ana Vidović, et al.. (2014). Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis. Medical Oncology. 31(3). 869–869. 31 indexed citations
2.
Konstantinov, Igor E. & Gradimir Janković. (2013). Alexander I. Ignatowski: a pioneer in the study of atherosclerosis.. PubMed. 40(3). 246–9. 17 indexed citations
3.
C̆olović, Milica, Nataša Čolović, Dejana Stanisavljević, et al.. (2012). Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients. Annals of Hematology. 91(9). 1363–1370. 11 indexed citations
4.
C̆olović, Milica, Nataša Čolović, Gradimir Janković, et al.. (2011). Mixed phenotype acute leukemia of T/myeloid type with a prominent cellular heterogeneity and unique karyotypic aberration 45,XY, dic(11;17). International Journal of Laboratory Hematology. 34(3). 290–294. 4 indexed citations
5.
Čolović, Nataša, Dragica Tomin, Ana Vidović, et al.. (2011). Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia. Biomedicine & Pharmacotherapy. 66(8). 578–582. 8 indexed citations
6.
Jurišić, Vladimir, Sonja Pavlović, Nataša Čolović, et al.. (2009). Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia. Journal of Genetics. 88(2). 149–152. 7 indexed citations
7.
Drakulić, Danijela, et al.. (2008). Pattern of trisomy 1q in hematological malignancies: a single institution experience. Cancer Genetics and Cytogenetics. 186(1). 12–18. 9 indexed citations
8.
C̆olović, Milica, et al.. (2007). Thirty patients with primary plasma cell leukemia: a single center experience. Medical Oncology. 25(2). 154–160. 31 indexed citations
9.
Janković, Gradimir, et al.. (2007). Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients. Cancer Genetics and Cytogenetics. 173(1). 57–62. 13 indexed citations
10.
Janković, Gradimir, et al.. (2005). A der(14)t(1;14)(q12;p11) in chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics. 160(1). 89–93. 11 indexed citations
11.
C̆olović, Milica, et al.. (2004). Acquired amegakaryocytic thrombocytopenia associated with proliferation of γ/δ TCR+ T‐lymphocytes and a BCR‐ABL (p210) fusion transcript. European Journal Of Haematology. 73(5). 372–375. 12 indexed citations
12.
Lazarević, Vladimir, et al.. (2003). A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia. Cancer Genetics and Cytogenetics. 148(1). 77–79. 6 indexed citations
13.
Lazarević, Vladimir, et al.. (2001). Clinical, Immunophenotypic and Cytogenetic Features of Megakaryocytic Blast Crisis of Chronic Myeloid Leukemia: A Single Institution Study.. PubMed. 18(2). 107–15. 1 indexed citations
14.
Čolović, Nataša, et al.. (2001). Prognostic significance of serum immunoglobulins in B-chronic lymphocytic leukemia. Archive of oncology. 9(2). 79–82. 11 indexed citations
15.
Janković, Gradimir, et al.. (2001). Hairy cell leukemia in first cousins and review of the literature. European Journal Of Haematology. 67(3). 185–188. 12 indexed citations
16.
C̆olović, Milica, Vladimir Lazarević, Radmilo Čolović, et al.. (1999). Hepatosplenic candidiasis after neutropenic phase of acute leukaemia. Medical Oncology. 16(2). 139–142. 4 indexed citations
17.
C̆olović, Milica, Gradimir Janković, Jelena Bila, Vesna Djordjević, & Wiernik Ph. (1998). Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature. Medical Oncology. 15(3). 199–201. 16 indexed citations
18.
C̆olović, Milica, et al.. (1996). Cytologically distinct acute leukemia in sibs exposed to the same leukemogen.. PubMed. 27(4). 209–10. 1 indexed citations
19.
C̆olović, Milica, et al.. (1996). Burkitt-like blast crisis in chronic myeloid leukemia. Medical Oncology. 13(2). 119–120. 2 indexed citations
20.
Janković, Gradimir, et al.. (1991). Neutrophil alkaline phosphatase activity in the urinary neutrophils of a patient with chronic myelogenous leukemia. American Journal of Hematology. 36(1). 67–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026